skip to main content
Show Results with:

Dose-escalation study for the targeting of CD44v + cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)

Gastric Cancer, 2017, Vol.20(2), pp.341-349 [Peer Reviewed Journal]

Full text available

Searching Remote Databases, Please Wait